| Metabolic modulation of glioblastoma with dichloroacetate ED Michelakis, G Sutendra, P Dromparis, L Webster, A Haromy, E Niven, ... Science translational medicine 2 (31), 31ra34-31ra34, 2010 | 880 | 2010 |
| Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer Z Gabos, R Sinha, J Hanson, N Chauhan, J Hugh, JR Mackey, ... Journal of Clinical Oncology 24 (36), 5658-5663, 2006 | 426 | 2006 |
| Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy … BS Abdulkarim, J Cuartero, J Hanson, J Deschênes, D Lesniak, S Sabri Journal of Clinical Oncology 29 (21), 2852, 2011 | 419 | 2011 |
| BCR-ABL down-regulates the DNA repair protein DNA-PKcs E Deutsch, A Dugray, B AbdulKarim, E Marangoni, L Maggiorella, ... Blood, The Journal of the American Society of Hematology 97 (7), 2084-2090, 2001 | 221 | 2001 |
| Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer O Graesslin, BS Abdulkarim, C Coutant, F Huguet, Z Gabos, L Hsu, ... Journal of clinical oncology 28 (12), 2032-2037, 2010 | 173 | 2010 |
| Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers B Abdulkarim, S Sabri, E Deutsch, H Chagraoui, L Maggiorella, J Thierry, ... Oncogene 21 (15), 2334-2346, 2002 | 164 | 2002 |
| Radiomics in glioblastoma: current status and challenges facing clinical implementation A Chaddad, MJ Kucharczyk, P Daniel, S Sabri, BJ Jean-Claude, T Niazi, ... Frontiers in oncology 9, 374, 2019 | 155 | 2019 |
| A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma J Bourhis, R De Crevoisier, B Abdulkarim, E Deutsch, A Lusinchi, ... International Journal of Radiation Oncology* Biology* Physics 46 (5), 1105-1108, 2000 | 141 | 2000 |
| Temozolomide induced hypermutation in glioma: evolutionary mechanisms and therapeutic opportunities P Daniel, S Sabri, A Chaddad, B Meehan, B Jean-Claude, J Rak, ... Frontiers in oncology 9, 41, 2019 | 140 | 2019 |
| Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells B Wen, E Deutsch, E Marangoni, V Frascona, L Maggiorella, ... British journal of cancer 85 (12), 2017-2021, 2001 | 136 | 2001 |
| Environmental, genetic, and molecular features of prostate cancer E Deutsch, L Maggiorella, P Eschwege, J Bourhis, JC Soria, B Abdulkarim The lancet oncology 5 (5), 303-313, 2004 | 120 | 2004 |
| β1-integrin circumvents the Antiproliferative effects of Trastuzumab in human epidermal growth factor receptor-2–positive breast cancer D Lesniak, Y Xu, J Deschenes, R Lai, J Thoms, D Murray, S Gosh, ... Cancer research 69 (22), 8620-8628, 2009 | 116 | 2009 |
| The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Z Gabos, J Thoms, S Ghosh, J Hanson, J Deschênes, S Sabri, ... Breast cancer research and treatment 124, 187-194, 2010 | 114 | 2010 |
| Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization D Garnier, B Meehan, T Kislinger, P Daniel, A Sinha, B Abdulkarim, ... Neuro-oncology 20 (2), 236-248, 2018 | 112 | 2018 |
| MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib M Chahal, Y Xu, D Lesniak, K Graham, K Famulski, JG Christensen, ... Neuro-oncology 12 (8), 822-833, 2010 | 97 | 2010 |
| Decreased DNA-PK activity in human cancer cells exhibiting hypersensitivity to low-dose irradiation S Vaganay-Juery, C Muller, E Marangoni, B Abdulkarim, E Deutsch, ... British Journal of Cancer 83 (4), 514-518, 2000 | 86 | 2000 |
| Prediction of survival with multi-scale radiomic analysis in glioblastoma patients A Chaddad, S Sabri, T Niazi, B Abdulkarim Medical & biological engineering & computing 56, 2287-2300, 2018 | 82 | 2018 |
| Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer D Lesniak, S Sabri, Y Xu, K Graham, P Bhatnagar, M Suresh, ... PloS one 8 (8), e71987, 2013 | 77 | 2013 |
| Metformin in combination with chemoradiotherapy in locally advanced non–small cell lung cancer: The OCOG-ALMERA randomized clinical trial T Tsakiridis, GR Pond, J Wright, PM Ellis, N Ahmed, B Abdulkarim, W Roa, ... JAMA oncology 7 (9), 1333-1341, 2021 | 75 | 2021 |
| Novel radiomic features based on joint intensity matrices for predicting glioblastoma patient survival time A Chaddad, P Daniel, C Desrosiers, M Toews, B Abdulkarim IEEE journal of biomedical and health informatics 23 (2), 795-804, 2018 | 74 | 2018 |
